← Back to Search

OCT for Normal Eyes

N/A
Waitlist Available
Research Sponsored by Optos, PLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Summary

This trial aims to gather eye images from healthy people using a light-based imaging test called OCT. The goal is to create a database of normal eye measurements for a device called P200TE.

Who is the study for?
This trial is for people who are at least 22 years old, can follow the study's procedures, and have signed the consent form. They must have normal eyes with a visual acuity of 20/40 or better but can have certain conditions like cataracts or past eye surgeries that don't affect the back part of the eye.
What is being tested?
The study aims to gather data using Optical Coherence Tomography (OCT) on participants with normal eyesight to create a reference database for a device called P200TE.
What are the potential side effects?
Since this trial involves non-invasive imaging with OCT and does not test any drugs or invasive treatments, there are no expected side effects related to medications. However, discomfort from bright lights during imaging may occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
GCC Thickness
Optic Nerve Head
RNFL Thickness
+1 more
Secondary study objectives
Adverse Events

Trial Design

1Treatment groups
Experimental Treatment
Group I: OCTExperimental Treatment1 Intervention
Device: P200TE The P200TE provides OCT imaging including retina topography and ONH (optic nerve head) scans.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
P200TE
2019
N/A
~370

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Optical Coherence Tomography (OCT) is a non-invasive imaging technique that captures high-resolution cross-sectional images of the retina. For patients with normal eyes, OCT is crucial as it allows for the early detection and monitoring of potential retinal and macular conditions that might not yet present symptoms. By identifying issues such as macular degeneration, diabetic retinopathy, or glaucoma at an early stage, OCT enables timely intervention, which can prevent progression and preserve vision. This proactive approach is essential for maintaining ocular health and preventing vision loss.
Optical coherence tomography findings in patients prior to cataract surgery regarded as unremarkable with ophthalmoscopy.Subthreshold laser treatment for retinal arterial macroaneurysm.

Find a Location

Who is running the clinical trial?

Optos, PLCLead Sponsor
18 Previous Clinical Trials
2,755 Total Patients Enrolled
~320 spots leftby Oct 2025